Clinical Trial Update: a Study of SHR1210 in Combination With Paclitaxel-albumin and Carboplatin in Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating SHR1210 in combination with paclitaxel-albumin and carboplatin for extensive stage small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• SHR1210 (SHR-1210)
• paclitaxel-albumin (paclitaxel-albumin)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN